IP Library Granted Patent US 9,908,856
Granted Patent B2
US 9,908,856 · App. 15/121,324 · Granted Mar 6, 2018

Therapeutic compounds

Inventors: Carl Wagner (Glendale, AZ); Pamela Marshall (Peoria, AZ); Peter Jurutka (Scottsdale, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
C07D249/18A61K31/505C07C57/50C07C223/06C07C309/31C07D209/08C07D213/48C07D213/74C07D213/79C07D215/227C07D235/10C07D239/42C07D241/20C07D241/28C07D307/79C07D333/54C07C2602/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,908,856
App. No.
15/121,324
Granted
Mar 6, 2018
Kind
B2
Abstract

The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.

Claims (35)

1. A compound of formulae II:

wherein:

X is N, Y is CH and Z is N;

X is N, Y is CH and Z is CH;

X is N, Y is N and Z is CH;

X is CH, Y is CH and Z is CH;

R 2 is H or methyl; and

R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br; wherein the ring containing X, Y, and Z is optionally substituted on carbon with one or more groups independently selected from halo;

or a salt thereof

provided the compound is not:

2. The compound of claim 1 which is a compound of formulae IIa, IIb, or IIc:

wherein:

R 2 is H or methyl; and

R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br;

or a salt thereof.

3. The compound of claim 1 which is a compound of formulae IIa or IIc:

wherein:

R 2 is H or methyl; and

R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br;

or a salt thereof.

4. The compound of claim 1 which is a compound of formulae IIc:

wherein:

R 2 is H or methyl; and

R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br;

or a salt thereof.

5. A compound selected from:

or a salt thereof.

6. A compound selected from:

or a salt thereof.

7. The compound,

or a salt thereof.

8. A compound selected from the group consisting of:

or a salt thereof.

9. A compound selected from the group consisting of:

or a salt thereof.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 9, 2021
From: ARIZONA STATE UNIVERSITY, TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056819/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2016
From: WAGNER, CARL; MARSHALL, PAMELA; JURUTKA, PETER
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 040086/0182 →
Continuity (2)
Provisional Application 61945020 · Feb 26, 2014
Related Publication 20170008859A1 · Jan 12, 2017